Literature DB >> 6230219

Vitamin therapy in the absence of obvious deficiency. What is the evidence?

L Ovesen.   

Abstract

Vitamins are a group of organic compounds occurring naturally in food and are necessary for good health. Lack of a vitamin may lead to a specific deficiency syndrome, which may be primary (due to inadequate diet) or secondary (due to malabsorption or to increased metabolic need), and it is rational to use high-dose vitamin supplementation in situations where these clinical conditions exist. However, pharmacological doses of vitamins are claimed to be of value in a wide variety of conditions which have no, or only a superficial, resemblance to the classic vitamin deficiency syndromes. The enormous literature on which these claims are based consists mainly of uncontrolled clinical trials or anecdotal reports. Only a few studies have made use of the techniques of randomisation and double-blinding. Evidence from such studies reveals a beneficial therapeutic effect of vitamin E in intermittent claudication and fibrocystic breast disease and of vitamin C in pressure sores, but the use of vitamin A in acne vulgaris, vitamin E in angina pectoris, hyperlipidaemia and enhancement of athletic capacity, of vitamin C in advanced cancer, and niacin in schizophrenia has been rejected. Evidence is conflicting or inconclusive as to the use of vitamin C in the common cold, asthma and enhancement of athletic capacity, of pantothenic acid in osteoarthritis, and folic acid (folacin) in neural tube defects. Most of the vitamins have been reported to cause adverse effects when ingested in excessive doses. It is therefore worthwhile to consider the risk-benefit ratio before embarking upon the use of high-dose vitamin supplementation for disorders were proof of efficacy is lacking.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6230219     DOI: 10.2165/00003495-198427020-00003

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  198 in total

1.  The treatment of intermittent claudication with vitamin E.

Authors:  M HAMILTON; G M WILSON; P ARMITAGE; J T BOYD
Journal:  Lancet       Date:  1953-02-21       Impact factor: 79.321

2.  Letter: Remission of sarcoid.

Authors:  H S Zucker
Journal:  N Y State J Med       Date:  1975-01

3.  Vitamin E in angina pectoris.

Authors:  W E SHUTE; E V SHUTE; A B VOGELSANG
Journal:  Lancet       Date:  1948-02-21       Impact factor: 79.321

4.  Some behavioral effects of ascorbic acid deficiency.

Authors:  R A Kinsman; J Hood
Journal:  Am J Clin Nutr       Date:  1971-04       Impact factor: 7.045

Review 5.  Retinoids, cancer, and the skin.

Authors:  P M Elias; M L Williams
Journal:  Arch Dermatol       Date:  1981-03

6.  Malignant external otitis and polymorphonuclear leukocyte migration impairment. Improvement with ascorbic acid.

Authors:  J Corberand; F Nguyen; B Fraysse; L Enjalbert
Journal:  Arch Otolaryngol       Date:  1982-02

7.  Influence of nicotinic acid on metabolism of cholesterol and triglycerides in man.

Authors:  S M Grundy; H Y Mok; L Zech; M Berman
Journal:  J Lipid Res       Date:  1981-01       Impact factor: 5.922

8.  Reduced chronic hemolysis during high-dose vitamin E administration in Mediterranean-type glucose-6-phosphate dehydrogenase deficiency.

Authors:  L Corash; S Spielberg; C Bartsocas; L Boxer; R Steinherz; M Sheetz; M Egan; J Schlessleman; J D Schulman
Journal:  N Engl J Med       Date:  1980-08-21       Impact factor: 91.245

9.  The effects of ascorbic acid and flavonoids on the occurrence of symptoms normally associated with the common cold.

Authors:  I M Baird; R E Hughes; H K Wilson; J E Davies; A N Howard
Journal:  Am J Clin Nutr       Date:  1979-08       Impact factor: 7.045

10.  The diurnal urinary excretion of oxalate and the effect of pyridoxine and ascorbate on oxalate excretion.

Authors:  H G Tiselius; L E Almgård
Journal:  Eur Urol       Date:  1977       Impact factor: 20.096

View more
  6 in total

Review 1.  Nutritional supplements in the ambulatory geriatric population. Should they be recommended?

Authors:  M L Freedman
Journal:  Drugs Aging       Date:  1991-05       Impact factor: 3.923

2.  In vivo gamma-tocopherol supplementation decreases systemic oxidative stress and cytokine responses of human monocytes in normal and asthmatic subjects.

Authors:  Jessica Wiser; Neil E Alexis; Qing Jiang; Weidong Wu; Carole Robinette; Robert Roubey; David B Peden
Journal:  Free Radic Biol Med       Date:  2008-03-12       Impact factor: 7.376

Review 3.  Isotretinoin. A review of its pharmacological properties and therapeutic efficacy in acne and other skin disorders.

Authors:  A Ward; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-07       Impact factor: 9.546

4.  Use of vitamin supplements in Finland.

Authors:  T Klaukka; E Riska; U M Kimmel
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 5.  Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases.

Authors:  Goran Bjelakovic; Dimitrinka Nikolova; Lise Lotte Gluud; Rosa G Simonetti; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2012-03-14

6.  Meta-regression analyses, meta-analyses, and trial sequential analyses of the effects of supplementation with beta-carotene, vitamin A, and vitamin E singly or in different combinations on all-cause mortality: do we have evidence for lack of harm?

Authors:  Goran Bjelakovic; Dimitrinka Nikolova; Christian Gluud
Journal:  PLoS One       Date:  2013-09-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.